Remove Communication Remove Definition Remove Vaccines
article thumbnail

Pharma needs to adapt its communications or be left behind

pharmaphorum

Amid the turmoil and the race to not only find a vaccine but also help to care for those who are battling the long-term effects of COVID-19, healthcare organisations need to sharpen their communication skills. Good, empathetic design allows the science to shine. Good, empathetic design allows the science to shine.

article thumbnail

5 Tips For Incoming PGY2 Pharmacy Residents

IDStewardship

Not too say it is as dramatic as the latter part of that statement, but it is a definite narrowing. For example in infectious diseases we have things like tropical medicine, travel vaccines, microbiology breakpoints, immunocompromised hosts, infection prevention, and regulatory requirements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alexion’s Camilla Harder Hartvig on making the impossible possible in rare disease

pharmaphorum

She says she is “truly amazed” about what the industry has achieved in such a short time when it comes to innovations, vaccines and treatments. I definitely believe that there will be a balance between the two modes, but we have now all seen that we can actually exceed expectations by being fully digital.

Hospitals 111
article thumbnail

The European Commission proposals – what practical impact?

European Pharmaceutical Review

of the draft revised Community Code provides a reduction in the basic data exclusivity period for innovative medicinal products from eight to six years, a revision which did not come as a great surprise to many. For instance, there is no definition in the proposed Directive of when a medicinal product is to be considered launched.

article thumbnail

Disrupted medical conferences: Lessons learnt

pharmaphorum

During the first half of 2020, surveys indicated that doctors would be reluctant to attend physical meetings in 2021, indicating preferences based mainly on fear of contracting COVID-19 and availability of vaccines. yes, if vaccines are available; 15.8% Jeff Bateman, head strategic communications [link]. yes; and 15.7%

Labelling 105
article thumbnail

Innovation across the healthcare system is needed to realise the value of medicines

pharmaphorum

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. The answer to this question comes back to our definition of value. And it all fuels the debate: are medicines a cost or an investment?

article thumbnail

New dawn for the EU’s joint procurement crisis response

Pharmaceutical Technology

The imminent rule changes will apply to crisis-relevant supplies of medical countermeasures, including both vaccines and therapeutics, where the threshold of a 'serious cross-border threat to health' is met. The new mechanism for collaboration will undoubtedly lead to other uncertainties.